Regarding SOX17 expression in cancer stroma niches, SOX17 immunoreactivity was found in endothelial cells of tumor‐penetrating vessels in 19 of 83 LUAD cases (Figure 1b–f). This evidence concerns the gene SOX17 and neoplasm.